CT

Europe’s lung screening training gaps sharpen focus on implementation

By Claudia Tschabuschnig

A new SOLACE survey reveals wide variation in lung cancer screening training across Europe, underscoring the need for harmonized standards and coordinated care pathways.

August 3, 2026

Lung Cancer Stages 400

RevealDx secures distribution deal, $3.4M investment from 4DMedical

By AuntMinnie.com staff writers

Under the agreement, 4DMedical will distribute RevealAI-Lung in the U.S., Europe, Australia, and New Zealand.

August 3, 2026

Median Technologies signs Canon Medical partnership for eyonis LCS

By AuntMinnie.com staff writers

Canon's subsidiary Olea Medical will leverage its CT imaging platform to support distribution of Median's software.

July 30, 2026

Business Handshake Intelligence 400 (1)

CT reveals severe craniofacial, ocular trauma from pager blasts

Head injuries were nearly universal, affecting 93.2% of patients.

July 20, 2026

Adobe Stock 517622853

Large Korean study adds evidence on contrast media hypersensitivity

By Claudia Tschabuschnig

A Korean study of almost 116,000 contrast media recipients adds new evidence on hypersensitivity risk factors, but a European expert says the findings should be interpreted in the context of current European practice.

July 14, 2026

Iodinated contrast media are among the most commonly administered agents in radiology.

Median gets CE marking for lung cancer screening software

By AuntMinnie.com staff writers

The CE marking follows the U.S. Food and Drug Administration (FDA)'s 510(k) clearance of eyonis LCS in February.

July 6, 2026

Imaging takes center stage in Europe's Safe Hearts Plan

By Claudia Tschabuschnig

Radiology and nuclear medicine are poised to play a central role in implementing the European Commission's Safe Hearts Plan, speakers said during a joint ESR/EANM event in Brussels.

July 2, 2026

The Safe Hearts Plan aims to shift healthcare systems toward prevention, earlier diagnosis, and more personalized care.

AuntMinnieEurope.com CT Insider

By Claudia Tschabuschnig

This Insider tracks the muscle hiding in plain sight on coronary CT, the guesswork still baked into contrast agent safety, and Germany's screening rollout hitting real-world friction.

July 1, 2026

Can side-chain chemistry help radiologists choose a safer contrast agent after a hypersensitivity reaction?

By Claudia Tschabuschnig

Choosing an alternative contrast agent after an allergic reaction often falls to clinical judgment. A new review examines whether side-chain chemistry can make that decision a little more evidence based.

July 1, 2026

Dr. Aart J. van der Molen, of Leiden University Medical Center in Leiden, the Netherlands, is the lead author of a review exploring side-chain chemistry as a guide for selecting alternative iodine-based contrast media.

Low muscle density on coronary CT linked to heart risk

Patients with skeletal muscle attenuation below the median had a higher risk of mortality and myocardial infarction.

June 30, 2026

An example of machine learning–based multiorgan body composition assessment (TotalSegmentator V2.0.4, 1.5-mm high-resolution model) in a 63-year-old man with obstructive coronary artery disease and a skeletal muscle attenuation below the median. (A) Transverse, (B) coronal, and (C) sagittal CT images and curved planar reformations of the (D) left, (E) circumflex, and (F) right coronary arteries.

Medneo acquires Ramsay Diagnostics UK mobile imaging fleet

By AuntMinnieEurope.com staff writers

Medneo is acquiring Ramsay Diagnostics UK's mobile MRI and CT fleet and a six-year contract to provide mobile imaging services.

June 30, 2026

Mri Scanner2 400

Micro-X enters new $1.9M research partnership

By AuntMinnie.com staff writers

Project continues work from Stage 1 of the Australian Government's Critical Technologies Challenge Program.

June 16, 2026

Am 2021 12 21 01 56 8422 Micro X Rsna 2021 400

Page 1 of 262